|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-9-14
|
|
pubmed:abstractText |
The advent of fibrin-binding molecular magnetic resonance (MR) contrast agents and advances in coronary MRI techniques offers the potential for direct imaging of coronary thrombosis. We tested the feasibility of this approach using a gadolinium (Gd)-based fibrin-binding contrast agent, EP-2104R (EPIX Medical Inc), in a swine model of coronary thrombus and in-stent thrombosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:BotnarRené MRM,
pubmed-author:BueckerArnoA,
pubmed-author:GrahamPhilip BPB,
pubmed-author:GuntherRolf WRW,
pubmed-author:KatohMarcusM,
pubmed-author:KatsimaglisGeorgeG,
pubmed-author:LaufferRandall BRB,
pubmed-author:ManningWarren JWJ,
pubmed-author:ParsonsEdward CECJr,
pubmed-author:SpuentrupElmarE,
pubmed-author:WeisskoffRobert MRM,
pubmed-author:WiethoffAndrea JAJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
14
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1463-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15238457-Animals,
pubmed-meshheading:15238457-Contrast Media,
pubmed-meshheading:15238457-Coronary Thrombosis,
pubmed-meshheading:15238457-Coronary Vessels,
pubmed-meshheading:15238457-Feasibility Studies,
pubmed-meshheading:15238457-Female,
pubmed-meshheading:15238457-Fibrin,
pubmed-meshheading:15238457-Fibrinogen,
pubmed-meshheading:15238457-Injections, Intra-Arterial,
pubmed-meshheading:15238457-Magnetic Resonance Angiography,
pubmed-meshheading:15238457-Pentetic Acid,
pubmed-meshheading:15238457-Sensitivity and Specificity,
pubmed-meshheading:15238457-Stents,
pubmed-meshheading:15238457-Sus scrofa
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
|
|
pubmed:affiliation |
Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass 02215, USA. rbotnar@bidmc.harvard.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
